On 3 July 2009, the Danish Medicines Agency made a decision on the future reimbursement status of medicinal products in ATC group A08 (antiobesity preparations, excl. diet products). In future, these medicinal products will not be eligible for general reimbursement.
In the factbox to the right, you can find a link to the letter containing the decision which the Danish Medicines Agency has sent to companies holding a marketing authorisation for medicinal products comprised by the decision.
Danish Medicines Agency, 6 July 2009